Top Markets
#1 Akedo Akedo +84.18%
#2 TENDIES TENDIES +73.28%
#3 Verus Coin Verus Coin +43.84%
#4 Threshold Network Threshold Network +42.58%
#5 Mubarak Mubarak +31.80%
#6 MultiversX MultiversX +27.43%
#7 Bitway Bitway +26.80%
#8 Cash Cat Cash Cat +24.01%
#9 Palladium Network Palladium Network +22.68%
#10 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
Coin of the day
Akedo Akedo
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Peringkat dalam Saham #17600
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Harga Saham
$8.16
Terakhir disinkronkan: 2025-06-26
Kapitalisasi Pasar
$234.57M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Regulus Therapeutics Inc. (RGLS)

Kategori

Healthcare
Jumlah saham beredar untuk Regulus Therapeutics Inc. (RGLS)
Jumlah saham beredar per March 2025: 66.17M
Menurut laporan keuangan terbaru dan harga saham Regulus Therapeutics Inc., jumlah saham beredar saat ini adalah 66.17M. Pada akhir December 2023, perusahaan memiliki 18.96M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Regulus Therapeutics Inc. (RGLS) dari 2010 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
2026 (TTM) 66.17M 17.44%
2024 56.35M 197.18%
2023 18.96M 24.25%
2022 15.26M 78.05%
2021 8.57M 145.03%
2020 3.50M 102.65%
2019 1.73M 97.97%
2018 871.86K 0.61%
2017 866.58K 96.90%
2016 440.11K 2.73%
2015 428.43K 16.61%
2014 367.42K 14.58%
2013 320.66K 368.55%
2012 68.44K 3,099.49%
2011 2.14K 0.00%
2010 2.14K 0.00%
Saham beredar untuk perusahaan serupa atau pesaing
Perusahaan Saham Beredar Perbedaan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 283.68%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -6.03%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 498.42%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 623.71%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH